Table: AFC-HD Ams Life Science -2018/19 group results

AFC-HD AMS Life Science

10/10/2019 07:10

Oct 10 (Reuters)- 
          AFC-HD Ams Life Science Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Aug 31, 2019    Aug 31, 2018   Aug 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           16.25           15.80          16.50         8.20    
               (+2.9 pct)      (+4.3 pct)     (+1.5 pct)    (-1.7 pct) 
  Operating      981 mln           1.02           1.05       460 mln   
               (-4.1 pct)      (-4.3 pct)     (+7.0 pct)   (-23.1 pct) 
  Recurring        1.01          982 mln          1.05       460 mln   
               (+3.3 pct)      (-5.6 pct)     (+3.5 pct)   (-25.6 pct) 
  Net
  Net            783 mln         736 mln        700 mln      300 mln   
               (+6.3 pct)      (+58.1 pct)    (-10.6 pct)  (-40.3 pct) 
  EPS           55.70 yen       58.28 yen      49.77 yen    21.33 yen  
  Ann Div       25.00 yen       20.00 yen      20.00 yen               
  -Q2 Div       10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div       15.00 yen       10.00 yen      10.00 yen               
  
  NOTE - AFC-HD Ams Life Science Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T